Harel Insurance Investments & Financial Services’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELOX
SCM
MMH
AFG
AS
CI
TRCT
Harel Insurance Investments & Financial Services's ELOX Position: Q2 2023 in Review
Harel Insurance Investments & Financial Services sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2023, closing a stake of 29,410 shares — an estimated $74K sold.
Harel Insurance Investments & Financial Services first reported a position in ELOX in Q4 2021 and held it in 6 quarters. The position peaked at $831K in Q4 2021. 16 funds tracked by Wall St. Rank hold ELOX as of Q2 2023.
- Harel Insurance Investments & Financial Services reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Harel Insurance Investments & Financial Services sold 29,410 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $74K.
- Harel Insurance Investments & Financial Services first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
- Harel Insurance Investments & Financial Services's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $831K in Q4 2021.
- 16 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2023.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2023, filed 17 Jul 2023.